VIPoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 19:58, 27 October 2015
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma historical perspective On the Web |
|
American Roentgen Ray Society Images of VIPoma historical perspective |
|
Risk calculators and risk factors for VIPoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
VIPoma was first described in 1958 by Verner and Morrison.[1]
Historical Perspective
VIPoma was first described in 1958 by Verner and Morrison.[1]
References
- ↑ 1.0 1.1 Maheshwari RR, Desai M, Rao VP, Palanki RR, Namburi RP, Reddy KT; et al. (2013). "Ischemic stroke as a presenting feature of VIPoma due to MEN 1 syndrome". Indian J Endocrinol Metab. 17 (Suppl 1): S215–8. doi:10.4103/2230-8210.119576. PMC 3830309. PMID 24251163.